SpacDesk4D Pharma PLC
Completed deSPAC · 1 SPAC · 1 closed · 0 announced
Longevity Acquisition Corp (Nasdaq: LOAC) was a blank-check company focused on the biotech and pharmaceutical sector that announced a business combination with 4D Pharma PLC in October 2020. 4D Pharma is a United Kingdom-based clinical-stage biopharmaceutical company engaged in developing live biotherapeutic medicines derived from the human microbiome. LOAC completed its initial public offering in 2020 and the transaction has since closed, providing 4D Pharma with access to U.S. public capital markets through the Nasdaq exchange. The deal represented one of several SPAC-driven pathways for early-stage European biotech companies seeking U.S. listings during that period. Sign up at SpacDesk for full historical filings, deal timelines, and analytics on LOAC and thousands of other SPAC transactions.
SPAC Counterparty (1)
| Symbol | Issuer | Status | Announced | Close | IPO Size | PIPE | Sponsor |
|---|---|---|---|---|---|---|---|
| LOAC | Longevity Acquisition Corp | Closed | 2020-10-21 | 2021-03-23 | $38.8M | — | Whale Management Corporation |
Key Filings
| Form | Filed | SPAC | Accession |
|---|---|---|---|
| 425 | 2021-02-26 | LOAC | 0001104659-21-028522 |
| DEFM14A | 2021-02-26 | LOAC | 0001104659-21-028406 |